Takuya Tsunoda

64 year

Health Technology

Health Services

Consumer Services

Profile

Dr. Takuya Tsunoda, MD PhD, is President & Representative Director at Immunas Pharma, Inc. and President & Representative Director at OncoTherapy Science, Inc. He is on the Board of Directors at Immunas Pharma, Inc. and OncoTherapy Science, Inc. Dr. Tsunoda was previously employed as an Assistant Research Scientist by City of Hope.
He received his undergraduate degree from Wakayama Medical University and a doctorate degree from Wakayama Medical University.

Former positions of Takuya Tsunoda

Companies	Position	End
City of Hope National Cancer Institute City of Hope National Cancer Institute Hospital/Nursing ManagementHealth Services City of Hope is a research and treatment center for cancer, diabetes and various life-threatening diseases. The center is founded in 1913 and is headquartered in Los Angeles, CA.	Corporate Officer/Principal	-
Immunas Pharma, Inc. Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million.	President	-
ONCOTHERAPY SCIENCE, INC.	President	-

See the detail of Takuya Tsunoda's experience

Training of Takuya Tsunoda

Wakayama Medical University

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies